Annual Cash & Cash Equivalents
$435.89 M
+$203.13 M+87.27%
31 December 2023
Summary:
Beam Therapeutics annual cash & cash equivalents is currently $435.89 million, with the most recent change of +$203.13 million (+87.27%) on 31 December 2023. During the last 3 years, it has risen by +$273.72 million (+168.79%). BEAM annual cash & cash equivalents is now -22.16% below its all-time high of $559.99 million, reached on 31 December 2021.BEAM Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$230.20 M
-$62.56 M-21.37%
30 September 2024
Summary:
Beam Therapeutics quarterly cash and cash equivalents is currently $230.20 million, with the most recent change of -$62.56 million (-21.37%) on 30 September 2024. Over the past year, it has increased by +$61.15 million (+36.18%). BEAM quarterly cash and cash equivalents is now -62.39% below its all-time high of $612.02 million, reached on 30 September 2021.BEAM Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BEAM Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +87.3% | +36.2% |
| 3 y3 years | +168.8% | -62.4% |
| 5 y5 years | +197.7% | +509.6% |
BEAM Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -22.2% | +168.8% | -62.4% | +47.1% |
| 5 y | 5 years | -22.2% | +1071.1% | -62.4% | +518.5% |
| alltime | all time | -22.2% | >+9999.0% | -62.4% | +518.5% |
Beam Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $230.20 M(-21.4%) |
| June 2024 | - | $292.76 M(+1.7%) |
| Mar 2024 | - | $287.85 M(-34.0%) |
| Dec 2023 | $435.89 M(+87.3%) | $435.89 M(+157.9%) |
| Sept 2023 | - | $169.05 M(-25.0%) |
| June 2023 | - | $225.54 M(-9.7%) |
| Mar 2023 | - | $249.77 M(+7.3%) |
| Dec 2022 | $232.77 M(-58.4%) | $232.77 M(+48.7%) |
| Sept 2022 | - | $156.51 M(-41.1%) |
| June 2022 | - | $265.62 M(-10.5%) |
| Mar 2022 | - | $296.82 M(-47.0%) |
| Dec 2021 | $559.99 M | $559.99 M(-8.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $612.02 M(+188.7%) |
| June 2021 | - | $212.01 M(+118.0%) |
| Mar 2021 | - | $97.24 M(-40.0%) |
| Dec 2020 | $162.17 M(+335.7%) | $162.17 M(+17.6%) |
| Sept 2020 | - | $137.90 M(+10.1%) |
| June 2020 | - | $125.30 M(-0.6%) |
| Mar 2020 | - | $126.05 M(+238.7%) |
| Dec 2019 | $37.22 M(-74.6%) | $37.22 M(-1.4%) |
| Sept 2019 | - | $37.76 M(-0.2%) |
| June 2019 | - | $37.85 M(-74.2%) |
| Dec 2018 | $146.44 M(+7603.5%) | $146.44 M |
| Dec 2017 | $1.90 M | - |
FAQ
- What is Beam Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Beam Therapeutics?
- What is Beam Therapeutics annual cash & cash equivalents year-on-year change?
- What is Beam Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Beam Therapeutics?
- What is Beam Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Beam Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of BEAM is $435.89 M
What is the all time high annual cash & cash equivalents for Beam Therapeutics?
Beam Therapeutics all-time high annual cash & cash equivalents is $559.99 M
What is Beam Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, BEAM annual cash & cash equivalents has changed by +$203.13 M (+87.27%)
What is Beam Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BEAM is $230.20 M
What is the all time high quarterly cash and cash equivalents for Beam Therapeutics?
Beam Therapeutics all-time high quarterly cash and cash equivalents is $612.02 M
What is Beam Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, BEAM quarterly cash and cash equivalents has changed by +$61.15 M (+36.18%)